Dr. Alejandro García
Ph.D in Neuroscience from the University of Salamanca. With more than 10 years of experience in research and innovation projects in the Healthcare sector. Specialized in Big Data and the application of digital technologies to health prevention and the improvement of the quality of life.
Master’s degree in PMP, International University of La Rioja (UNIR).
Master’s degree in Quality assurance, environment, R&D and laboral risks, integrated management systems, Spanish National Distance Education University (UNED).
PhD. In Neuroscience, University of Salamanca
Degree in Biochemistry, University of Salamanca.
Degree in Biology, University of Salamanca.
Dr. Alejandro García initially developed his professional career in biomedical research, both in fundamental research in the public sector and in the pharmaceutical industry in the development of new cell therapies and medical devices. Currently he develops his activity as Head of Research and Innovation at ATAM in the development of digital and technological projects applied to health, such as Apps and wearables for eHealth and in the use of Big Data and Artificial Intelligence to obtain health predictions.
Relating his academic experience Dr. Alejandro García has been a collaborating professor in the Biochemistry Department of the University of Salamanca and he has been trained in digital tools for e-learning.
- Alpha-fetoprotein (AFP) modulates the effect of serum albumin on brain development by restraining the neurotrophic effect of oleic acid.
Brain Research 2015 ; DOI: 10.1016/j.brainres.2015.07.021
- Oleic acid synthesized in the periventricular zone promotes axonogenesis in the striatum during brain development
Journal of Neurochemistry 2010; DOI: 10.1111/j.1471-4159.2010.06891.x